| Literature DB >> 34326814 |
Nicola Minuto1, Marta Bassi2,3, Carolina Montobbio2,3, Francesco Vinci2,3, Claudia Mercuri2,3, Francesca Nastasia Perri2,3, Mara Cabri3, Maria Grazia Calevo4, Giuseppe d'Annunzio1, Mohamad Maghnie1,2,3.
Abstract
Aims: The purpose of the study was to evaluate the impact of the lockdown established by the Italian government to limit the spread of Coronavirus disease (COVID-19) on glycemic control in a large sample of patients with type 1 diabetes (T1D) based on age, type of insulin therapy, number of telemedicine visits and physical activity. Material andEntities:
Keywords: COVID-19; children; continuous glucose monitoring; glycemic control; physical activity; type 1 diabetes
Mesh:
Year: 2021 PMID: 34326814 PMCID: PMC8315148 DOI: 10.3389/fendo.2021.690222
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Demographic data, type of insulin therapy and weekly exercise time at T0.
| (n = 202) | |
|---|---|
|
| 18.30 ± 6.43 |
|
| 17 (6–39) |
|
| 8.10 ± 4.18 |
|
| 8 (1–20) |
|
| |
|
| |
| Female N (%) | 95 (47) |
| Male N (%) | 107 (53) |
|
| |
| CSII N (%) | 168 (83.2) |
| MDI N (%) | 34 (16.8) |
|
| |
| None N (%) | 48 (23.8) |
| Single visit N (%) | 112 (55.4) |
| 2 or more visits N (%) | 42 (20.8) |
|
| |
| Primary school N (%) | 7 (3.5) |
| First grade secondary school N (%) | 42 (20.8) |
| Second grade secondary school N (%) | 58 (28.7) |
| University students/young adults N (%) | 95 (47.0) |
|
| |
| No physical activity N (%) | 38 (19.6) |
| Physical activity <3 h per week N (%) | 27 (13.9) |
| Intense physical activity ≥3 h wks N (%) | 129 (66.5) |
CSII, continuous subcutaneous insulin infusion; MDI, multiple daily injection.
Primary outcome: Glycemic control at T0 and T1.
| T0 (N = 202) | T1 (N = 202) | p-value | |
|---|---|---|---|
| Coefficient of variation (%) | 36.53 ± 5.76 | 34.76 ± 5.76 | ≤0.0001 |
| SD (mg/dl) | 64.26 ± 14.26 | 59.15 ± 13.78 | ≤0.0001 |
| HbA1c (%) | 7.76 ± 1.04 | 7.56 ± 1.05 | ≤0.0001 |
| TIR (%) | 54.58 ± 16.67 | 59.09 ± 17.65 | ≤0.0001 |
| TAR (%) | 42.48 ± 17.78 | 38.50 ± 18.45 | ≤0.0001 |
| TAR >250 mg/dl (%) | 16.25 ± 12.31 | 12.81 ± 11.59 | ≤0.0001 |
| TBR (%) | 2.83 ± 2.91 | 2.38 ± 3.06 | ≤0.002 |
| TBR <54 mg/dl (%) | 0.59 ± 0.92 | 0.48 ± 1.06 | ≤0.01 |
| Mean glucose value (mg/dl) | 176.16 ± 29.87 | 170.18 ± 30.14 | ≤0.0001 |
| Sport (hours/week) | 4.64 ± 4.24 | 2.46 ± 3.22 | ≤0.0001 |
SD, standard deviation; TIR, time in range (70–180 mg/dl); TAR, time above range (>180 mg/dl); TAR >250, time above range (>250 mg/dl); TBR, time below range (<70 mg/dl); TBR <54, time below range (<54 mg/dl).
Secondary outcome: Glycemic control in relation to age groups at T0 and T1.
| Age ≥6 y <10 y (N = 7) | Age ≥10 y <14 y (N = 42) | Age ≥14 y <18 y (N = 58) | Age ≥18 y (N = 95) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | p-value | T0 | T1 | p-value | T0 | T1 | p-value | T0 | T1 | p-value | |
| Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | Mean ± SD Median (IQR) | |||||
| Coefficient of variation (%) | 36.99 ± 9.19 | 34.07 ± 5.25 | 0.24 | 37.55 ± 6.02 | 34.13 ± 5.68 |
| 36.92 ± 5.24 | 36.13 ± 5.34 | 0.31 | 35.82 ± 5.66 | 34.27 ± 6.02 |
|
| SD (mg/dL) | 61.14 ± 15.91 | 55.29 ± 13.34 | 0.07 | 65 ± 14.01 | 58.43 ± 11.74 |
| 67.33 ± 15.52 | 63.40 ± 15.08 |
| 62.28 ± 13.27 | 57.16 ± 13.43 |
|
| HbA1c (%) | 7.54 ± 1.08 | 7.33 ± 1.12 | 0.15 | 7.66 ± 1.01 | 7.62 ± 0.96 | 0.53 | 7.95 ± 1.09 | 7.76 ± 1.31 |
| 7.71 ± 1.02 | 7.42 ± 0.89 |
|
| TIR (%) | 58.33 ± 21.14 | 61.49 ± 19.76 | 0.50 | 55.74 ± 16.30 | 56.84 ± 16.91 | 0.28 | 51.96 ± 16.73 | 56.71 ± 19.42 |
| 55.40 ± 16.53 | 61.37 ± 16.62 |
|
| TAR (%) | 39.21 ± 22.25 | 35.27 ± 20.99 | 0.13 | 40.31 ± 16.77 | 40.96 ± 17.78 | 0.97 | 45.38 ± 18.01 | 40.84 ± 20.75 |
| 41.92 ± 17.79 | 36.22 ± 16.98 |
|
| TAR >250 mg/dl (%) | 12.07 ± 11.14 | 9.56 ± 11.15 | 0.50 | 16.36 ± 12.86 | 12.74 ± 9.99 |
| 18.63 ± 12.13 | 16.22 ± 15.09 |
| 15.06 ± 12.18 | 11.01 ± 9.30 |
|
| 11.65 (16.40) | 10.70 (11.85) | 120 (21.60) | 12.30 (16.70) | 8.50 (15.70) | ||||||||
| TBR (%) | 2.49 ± 3.09 | 3.24 ± 3.25 | 0.12 | 3.34 ± 3.36 | 2.20 ± 2.51 |
| 2.60 ± 2.41 | 2.32 ± 2.14 | 0.39 | 2.77 ± 3.0 | 2.42 ± 3.70 |
|
| 2.50 (3.70) | 1.40 (2.70) | 1.80 (3.00) | 1.60 (3.00) | 1.80 (3.60) | 1.30 (2.30) | |||||||
| TBR <54 mg/dl (%) | 0.79 ± 1.60 | 0.87 ± 1.32 | 0.35 | 0.80 ± 1.17 | 0.49 ± 0.94 |
| 0.52 ± 0.79 | 0.40 ± 0.50 | 0.58 | 0.53 ± 0.79 | 0.49 ± 1.32 | 0.06 |
| 0.20 (0.20) | 0.40 (0.60) | 0.40 (0.80) | 0.20 (0.70) | 0.20 (0.50) | 0.20 (0.60) | 0.20 (0.50) | 0.10 (0.40) | |||||
| Mean glucose (mg/dl) | 169.7 ± 30.87 | 163 ± 31.34 | 0.09 | 173.43 ± 29 | 172 ± 27.43 | 0.43 | 181.6 ± 31.41 | 175.9 ± 37.64 | 0.02 | 174.6 ± 29.23 | 166.4 ± 25.54 |
|
| Sport (hours/week) | 4.36 ± 0.94 | 0.14 ± 0.38 |
| 6.01 ± 4.06 | 1.82 ± 2.32 |
| 5.14 ± 4.20 | 2.72 ± 3.40 |
| 3.74 ± 4.33 | 2.77 ± 3.49 |
|
| 0.00 (0.00) | 5.00 (3.75) | 1.00 (2.00) | 4.00 (4.00) | 2.00 (4.00) | 3.00 (5.40) | 2.00 (4.00) | ||||||
SD, standard deviation; TIR, time in range (70–180 mg/dl); TAR, time above range (>180 mg/dl); TAR >250, time above range (>250 mg/dl); TBR, time below range (<70 mg/dl); TBR <54, time below range (<54 mg/dl). bold = statistically significant values.
Figure 1Changes in weekly sports hours for each age at T0 (before the lockdown) and at T1 (lockdown period). Only one children of seven in “primary school children” group maintained physical activity ( ).
Study population divided by age and by sport group at T0 and T1 (N = 194).
| T0 | T1 | |||||
|---|---|---|---|---|---|---|
| No sport (N = 38) | Sport <3 h (N = 27) | Sport ≥3 h (N = 129) | No sport (N = 77) | Sport <3 h (N = 46) | Sport ≥3 h (N = 71) | |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
|
| 0 | 0 | 7 (100) | 6 (85.7) | 1 (14.3) | 0 |
|
| 2 (5) | 4 (10) | 34 (85) | 14 (35) | 18 (45) | 8 (20) |
|
| 8 (14) | 8 14) | 41 (72) | 23 (40.4) | 10 (17.5) | 24 (42.1) |
|
| 28 (31.1) | 15 (16.7) | 47 (52.2) | 34 (37.8) | 17 (18.9) | 39 (43.3) |
Secondary outcome: Glycemic control in relation to physical activity at T0 and T1 (N = 194).
| T0 | T1 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No sport (N = 38) | Sport <3 h (N = 27) | Sport ≥3 h (N = 129) | p-value No sport | p-value No sport | p-valueSport <3 h | No sport (N = 77) | Sport <3 h (N = 46) | Sport ≥3 h (N = 71) | p-value No sport | p-value No sport | p-value Sport <3 h | |
| Mean ± SD median (IQR) | Mean ± SD median (IQR) | Mean ± SD median (IQR) | Mean ± SD median (IQR) | Mean ± SD median (IQR) | Mean ± SD median (IQR) | |||||||
| Coefficient of variation (%) | 36.47 ± 5.88 | 34.48 ± 5.99 | 36.92 ± 5.73 | 0.17 | 0.68 |
| 35.39 ± 5.47 | 33.06 ± 5.91 | 35.09 ± 6.04 | 0.02 | 0.58 | 0.09 |
| SD (mg/dl) | 66.71 ± 15.53 | 61.07 ± 15.04 | 63.96 ± 13.97 | 0.19 | 0.40 | 0.28 | 63.04 ± 14.18 | 55.72 ± 12.94 | 57.14 ± 13.47 |
|
| 0.78 |
| HbA1c (%) | 8.02 ± 1.13 | 7.77 ± 0.87 | 7.67 ± 1.05 | 0.56 | 0.15 | 0.49 | 7.85 ± 1.11 | 7.53 ± 1.12 | 7.28 ± 0.89 | 0.11 |
| 0.26 |
| TIR (%) | 51.56 ± 16.74 | 55.51 ± 14.41 | 55.63 ± 17.18 | 0.42 | 0.25 | 0.86 | 54.12 ± 17.01 | 59.69 ± 19.30 | 63.98 ± 16.29 | 0.07 |
| 0.28 |
| TAR (%) | 49.90 ± 18.13 | 42.83 ± 15.38 | 41.07 ± 18.23 | 0.63 | 0.21 | 0.56 | 44.57 ± 18.04 | 38.32 ± 20.42 | 33.24 ± 16.52 | 0.09 |
| 0.19 |
| TAR >250 mg/dl (%) | 18.94 ± 14.45 | 13.97 ± 10.04 | 15.78 ± 12.19 | 0.25 | 0.30 | 0.64 | 16.07 ± 13.09 | 12.16 ± 12.16 | 9.94 ± 8.91 |
|
| 0.63 |
| 15.25 (22.60) | 11.40 (16.10) | 12.30 (17.80) | 13.50 (18.50) | 8.55 (17.30) | 8.70 (10.60) | |||||||
| TBR (%) | 2.71 ± 3.13 | 1.53 ± 2.14 | 3.11 ± 2.96 | 0.07 | 0.25 |
| 2.32 ± 2.64 | 2.0 ± 2.24 | 2.66 ± 3.95 | 0.53 | 0.70 | 0.29 |
| 2.05 (3.70) | 0.70 (1.30) | 2.10 (3.50) | 1.30 (2.80) | 1.20 (3.10) | 1.60 (2.80) | |||||||
| TBR <54 mg/dl (%) | 0.41 ± 0.59 | 0.41 ± 1.01 | 0.67 ± 0.98 | 0.06 | 0.29 |
| 0.51 ± 0.96 | 0.29 ± 0.41 | 0.58 ± 1.44 | 0.23 | 0.62 | 0.48 |
| 0.20 (0.40) | 0.10 (0.30) | 0.30 (0.70) | 0.20 (0.50) | 0.10 (0.40) | 0.10 (0.50) | |||||||
| Mean glucose (mg/dl) | 183.47 ± 33.66 | 176.19 ± 24.79 | 173.59 ± 30.18 | 0.50 | 0.15 | 0.51 | 178.45 ± 31.89 | 169.3 ± 32 | 162.3 ± 25.45 | 0.11 |
| 0.30 |
SD, standard deviation; TIR, time in range* (70–180 mg/dl); TAR, time above range (>180 mg/dl); TAR >250, time above range (>250 mg/dl); TBR, time below range (<70 mg/dl); TBR <54, time below range (<54 mg/dl). bold = statistically significant values.
Analysis of the data at T1 of the 129 patients belonging to the “intense physical activity” group at T0.
| T1(N = 129) | ||||||
|---|---|---|---|---|---|---|
| No sport (N = 36) | Sport <3 h (N = 37) | Sport ≥3 h (N = 56) | p-value no sport | p-value no sport | p-value sport <3 h | |
| Mean ± SD | Mean ± SD | Mean ± SD | ||||
| Coefficient of variation (%) | 36.13 ± 5.42 | 33.42 ± 4.96 | 35.52 ± 6.38 | 0.02 | 0.52 | 0.06 |
| SD (mg/dl) | 63.64 ± 14.04 | 56.84 ± 11.90 | 57.55 ± 13.83 | 0.05 | 0.07 | 0.96 |
| HbA1c (%) | 7.77 ± 1 | 7.59 ± 1.2 | 7.25 ± 0.88 | 0.36 |
| 0.17 |
| TIR | 54.76 ± 16.04 | 58.17 ± 20.46 | 64.11 ± 16.28 | 0.29 |
| 0.16 |
| TAR | 42.84 ± 17.29 | 39.66 ± 21.79 | 32.72 ± 16.35 | 0.35 |
| 0.12 |
| TAR >250 (mg/dl) | 15.31 ± 11.24 | 13.42 ± 12.78 | 9.80 ± 8.76 | 0.25 |
| 0.31 |
| TBR | 2.41 ± 2.79 | 2.18 ± 2.27 | 3.02 ± 4.31 | 0.66 | 0.43 | 0.24 |
| TBR <54(mg/dl) | 0.57 ± 1.11 | 0.32 ± 0.44 | 0.68 ± 1.59 | 0.42 | 0.86 | 0.50 |
| Mean glucose (mg/dl) | 176.30 ± 28.71 | 171 ± 34.33 | 161.4 ± 25.21 | 0.34 |
| 0.19 |
bold = statistically significant values.